1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
2
|
Sewnaik A, Hoorweg JJ, Kneqt PP, Wieringa
MH, van der Beek JM and Kerrebijn JD: Treatment of hypopharyngeal
carcinoma: Analysis of nationwide study in the Netherlands over a
10-year period. Clin Otolaryngol. 30:52–57. 2005. View Article : Google Scholar : PubMed/NCBI
|
3
|
Gupta T, Chopra S, Aqarwal JP, Laskar SG,
D'cruz AK, Shrivastava SK and Dinshaw KA: Squamous cell carcinoma
of the hypopharynx: Single-institution outcome analysis of a large
cohort of patients treated with primary non-surgical approaches.
Acta Oncol. 48:541–548. 2009. View Article : Google Scholar
|
4
|
Semrau R, Mueller RP, Stuetzer H, Staar S,
Schroeder U, Guntinas-Lichius O, Kocher M, Eich HT, Dietz A,
Flentje M, et al: Efficacy of intensified hyperfractionated and
accelerated radiotherapy and concurrent chemotherapy with
carboplatin and 5-fluorouraceil: Updated results of a randomized
multicentric trial in advanced head-and-neck cancer. Int J Radiat
Oncol Biol Phys. 64:1308–1316. 2006. View Article : Google Scholar : PubMed/NCBI
|
5
|
Ashhab Y, Alian A, Polliack A, Panet A and
Ben Yehuda D: Two splicing variants of a new inhibitor of apoptosis
gene with different biological properties and tissue distribution
pattern. FEBS Lett. 495:56–60. 2001. View Article : Google Scholar : PubMed/NCBI
|
6
|
Deveraux QL and Reed JC: IAP family
proteins-suppressors of apoptosis. Genes Dev. 13:239–252. 1999.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Deveraux QL, Stennicke HR, Salvesen GS and
Reed JC: Endogenous inhibitors of caspases. J Clin Immunol.
19:388–398. 1999. View Article : Google Scholar
|
8
|
Liu B, Han M, Wen JK and Wang L:
Livin/ML-IAP as a new target for cancer treatment. Cancer Lett.
250:168–176. 2007. View Article : Google Scholar : PubMed/NCBI
|
9
|
Wang L, Zhang Q, Liu B, Han M and Shan B:
Challenge and promise: Roles for Livin in progression and therapy
of cancer. Mol Cancer Ther. 7:3661–3669. 2008. View Article : Google Scholar : PubMed/NCBI
|
10
|
Vucic D, Stennicke HR, Pisabarro MT,
Salvesen GS and Dixit VM: ML-IAP, a novel inhibitor of apoptosis
that is preferentially expressed in human melanomas. Curr Biol.
10:1359–1366. 2000. View Article : Google Scholar : PubMed/NCBI
|
11
|
Keshet Y and Seger R: The MAP kinase
signaling cascades: A system of hundreds of components regulates a
diverse array of physiological functions. Methods Mol Biol.
661:3–38. 2010. View Article : Google Scholar : PubMed/NCBI
|
12
|
Pratilas CA and Solit DB: Targeting the
mitogen-activated protein kinase pathway: Physiological feedback
and drug response. Clin Cancer Res. 16:3329–3334. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Bermudez O, Pagès G and Gimond C: The
dual-specificity MAP kinase phosphatases: Critical roles in
development and cancer. Am J Physiol Cell Physiol. 299:C189–C202.
2010. View Article : Google Scholar : PubMed/NCBI
|
14
|
Haagenson KK and Wu GS: Mitogen activated
protein kinase phosphatases and cancer. Cancer Biol Ther.
9:337–340. 2010. View Article : Google Scholar : PubMed/NCBI
|
15
|
Lee DH, Yoon TM, Kim SA, Park YL, Lee KH,
Lim SC, Lee JK and Joο YE: Relationship between expression of Livin
and the biological behavior of human oral squamous cell carcinoma.
Oncol Rep. 32:2453–2460. 2014.PubMed/NCBI
|
16
|
Badran A, Yoshida A, Ishikawa K, Goi T,
Yamaguchi A, Ueda T and Inuzuka M: Identification of a novel splice
variant of the human anti-apoptopsis gene survivin. Biochem Biophys
Res Commun. 314:902–907. 2004. View Article : Google Scholar : PubMed/NCBI
|
17
|
Eckelman BP, Salvesen GS and Scott FL:
Human inhibitor of apoptosis proteins: Why XIAP is the black sheep
of the family. EMBO Rep. 7:988–994. 2006. View Article : Google Scholar : PubMed/NCBI
|
18
|
Roy N, Deveraux QL, Takahashi R, Salvesen
GS and Reed JC: The c-IAP-1 and c-IAP-2 proteins are direct
inhibitors of specific caspases. EMBO J. 16:6914–6925. 1997.
View Article : Google Scholar
|
19
|
Vaux DL and Silke J: Mammalian
mitochondrial IAP binding proteins. Biochem Biophys Res Commun.
304:499–504. 2003. View Article : Google Scholar : PubMed/NCBI
|
20
|
Deveraux QL, Roy N, Stennicke HR, Van
Arsdale T, Zhou Q, Srinivasula SM, Alnemri ES, Salvesen GS and Reed
JC: IAPs block apoptotic events induced by caspase-8 and cytochrome
c by direct inhibition of distinct caspases. EMBO J. 17:2215–2223.
1998. View Article : Google Scholar : PubMed/NCBI
|
21
|
Deveraux QL, Takahashi R, Salvesen GS and
Reed JC: X-linked IAP is a direct inhibitor of cell-death
proteases. Nature. 388:300–304. 1997. View
Article : Google Scholar : PubMed/NCBI
|
22
|
Cho SB, Lee WS, Park YL, Kim N, Oh HH, Kim
MY, Oak CY, Chung CY, Park HC, Kim JS, et al: Livin is associated
with the invasive and oncogenic phenotypes of human hepatocellular
carcinoma cells. Hepatol Res. 45:448–457. 2015. View Article : Google Scholar
|
23
|
DeBerardinis RJ, Lum JJ, Hatzivassiliou G
and Thompson CB: The biology of cancer: Metabolic reprogramming
fuels cell growth and proliferation. Cell Metab. 7:11–20. 2008.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Graña X and Reddy EP: Cell cycle control
in mammalian cells: Role of cyclins, cyclin dependent kinases
(CDKs), growth suppressor genes and cyclin-dependent kinase
inhibitors (CKIs). Oncogene. 11:211–219. 1995.PubMed/NCBI
|
25
|
Kasof GM and Gomes BC: Livin, a novel
inhibitor of apoptosis protein family member. J Biol Chem.
276:3238–3246. 2001. View Article : Google Scholar
|
26
|
Chen YS, Li HR, Lin M, Chen G, Xie BS, Xu
NL and Lin LF: Livin abrogates apoptosis of SPC-A1 cell by
regulating JNKI signaling pathway. Mol Biol Rep. 37:2241–2247.
2010. View Article : Google Scholar
|
27
|
Sanna MG, da Silva Correia J, Ducrey O,
Lee J, Nomoto K, Schrantz N, Deveraux QL and Ulevitch RJ: IAP
suppression of apoptosis involves distinct mechanisms: The
TAK1/JNK1 signaling cascade and caspase inhibition. Mol Cell Biol.
22:1754–1766. 2002. View Article : Google Scholar : PubMed/NCBI
|